This study identified the effects of rapamycin on OSA-associated renal injury. Inhibiting the mTOR signaling pathway by rapamycin can significantly reduce the levels of NLRP3 and organ damage caused by OSA. This evidence concerns the gene MTOR and obstructive sleep apnea syndrome.